Epigenic Therapeutics Raises $20 Million In Series Angel And Pre-A Funding To Advance Next Generation Gene Editing Therapy
Amount Raised
$20 Million
Round Type
Series A
ShanghaiBiotechnologyHealth CareresearchDescription
Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for wide variety of diseases, today announced it has secured $20 million in Series Angel and Pre-A funding. Series Pre-A funding is jointly invested by Morningside Venture Capital, Kingray Capital, Trinity Innovation Fund and TigerYeah Capital. Angel investor FountainBridge Capital is also participating.
Quick answer
Epigenic Therapeutics raised $20 Million in a Series A round, dated August 6, 2022. Epigenic Therapeutics is based in Shanghai, Shanghai, China.
- How much did Epigenic Therapeutics raise?
- Epigenic Therapeutics raised $20 Million in a Series A round on August 6, 2022.
- What does Epigenic Therapeutics do?
- Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases.
- Where is Epigenic Therapeutics based and how big is it?
- Epigenic Therapeutics is based in Shanghai, Shanghai, China. Fundz records about 13 employees.
- Who are the decision-makers at Epigenic Therapeutics?
- Fundz holds 2 contacts at Epigenic Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Epigenic Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Gameto raised an undisclosed amount (Funding Round) on September 14, 2022.
- Hera Biotech raised $1.9M (Seed) on August 24, 2022.
- BNB Plus raised $3.6M (Seed) on August 9, 2022.
- Kernal Biologics raised $25M (Series A) on July 7, 2022.
- Faeth Therapeutics raised $47M (Funding Round) on June 30, 2022.
- Surgimate raised an undisclosed amount (Corporate Round) on September 20, 2022.
Who to call at Epigenic Therapeutics, and when
A new round usually means Epigenic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Epigenic Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Epigenic Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Epigenic Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Epigenic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEpigenic Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.